[Supraventricular paroxysmal tachycardias during pregnancy: the therapeutic tactics and prognosis].
The paper contains recommendations on treatment of supraventricular paroxysmal tachycardias (SVPT) during pregnancy. The recommendations are based on contemporary literature data and authors" own data. SVPT in postural syndrome are shown to be benign and to demand no continuous antiarrhythmic therapy, while tachycardiac attacks are terminated by vagal tests and adenosine application. Relapsing and steady forms of SVPT with a high heart rate are accompanied by subjective symptoms and require preventive antiarrhythmic therapy, which should be conducted considering risk/benefit ratio. According to the authors, sotalol is the most effective and safe pharmaceutical.
Mravian
S R
SR
Petrukhin
V A
VA
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D011247:Pregnancy; D011379:Prognosis; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology*; D013617:Tachycardia, Supraventricular / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology*
D000889:Anti-Arrhythmia Agents